Our data confirm the oncogenic role of NEAT1 and the tumor suppressor role of miR-370-3p in GBM by using patient-derived GSCs, which represent a valuable tool to obtain data to be translated onto clinical settings. This evidence concerns the gene NEAT1 and glioblastoma.